The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–221 of 221
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
Field, S. K. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.811 · Cited by 36
Phosphodiesterase 4D and heart failure: a cautionary tale
Lehnart, S. E., & Marks, A. R. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.5.677 · Cited by 35
Phosphodiesterase 4-selective inhibition: novel therapy for the inflammation of COPD
Jeffery, P. K. (2004) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2004.09.027 · Cited by 35
Franceschi, L. D., Platt, O. S., Malpeli, G., Janin, A., Scarpa, A., Lebœuf, C., Beuzard, Y., Payen, E., & Brugnara, C. (2008) · The FASEB Journal · doi:10.1096/fj.07-098921 · Cited by 34
Defect of alveolar regeneration in pulmonary emphysema: role of lung fibroblasts.
Plantier, L., Boczkowski, J., & Crestani, B. (2007) · PubMed Central · Cited by 32
Glucocorticoids and TGF-β1 Synergize in Augmenting Fibroblast Mediated Contraction of Collagen Gels
Wen, F., Sköld, C. M., Liu, X.-D., Ertl, R. F., Zhu, Y. K., Kohyama, T., Wang, H., & Rennard, S. I. (2001) · Inflammation · doi:10.1023/a:1007170622699 · Cited by 31
Zhang, H., Lawson, W. E., Polosukhin, V. V., Pozzi, A., Blackwell, T. S., Litingtung, Y., & Chiang, C. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070226 · Cited by 30
Mori, H., Nose, T., Ishitani, K., Kasagi, S., Souma, S., Akiyoshi, T., Kodama, Y., Mori, T., Kondo, M., Sasaki, S., et al. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00173.2007 · Cited by 29
Baudouin-Legros, M., Hamdaoui, N., Borot, F., Fritsch, J., Ollero, M., Planelles, G., & Edelman, A. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000113749 · Cited by 27
Cavarra, E., Fardin, P., Fineschi, S., Ricciardi, A., Cunto, G. D., Sallustio, F., Zorzetto, M., Luisetti, M., Pfeffer, U., Lungarella, G., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90382.2008 · Cited by 25
Self-citationPulmonary fibroblasts, an emerging target for anti-obstructive drugs
Racké, K., Haag, S., Bahulayan, A., & Warnken, M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0264-0 · Cited by 25
Neutrophil capture by selectins on endothelial cells exposed to cigarette smoke
Stone, P. C. W., Fisher, A. C., Rainger, G. E., & Nash, G. B. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00800-8 · Cited by 20
Later Developments: Molecular Keys to Age-Related Memory Impairment
Barad, M. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00009 · Cited by 18
Wohlsen, A., Hirrle, A., Tenor, H., Marx, D., & Beume, R. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.005 · Cited by 18
Self-citationZhao, H. L., Guan, Q., Smith, C. J., & Quilley, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.016 · Cited by 15
Cytokines modulate cilomilast response in lung fibroblasts
Kohyama, T., Liu, X., Wen, F., Kobayashi, T., Fang, Q., Abe, S., Cieslinski, L. B., Barnette, M. S., & Rennard, S. I. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.01.007 · Cited by 15
Chronic Obstructive Pulmonary Disease
Weinberger, S. E., Cockrill, B. A., & Mandel, J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-5034-6.50009-9 · Cited by 14
The Neutrophil and Its Special Role in Chronic Obstructive Pulmonary Disease
Sapey, E., & Stockley, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374001-4.00014-6 · Cited by 12
Barnes, P. J., & Rennard, S. I. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374001-4.00034-1 · Cited by 10
Future options for disease intervention: important advances in phosphodiesterase 4 inhibitors
McIvor, A. (2007) · European Respiratory Review · doi:10.1183/09059180.00010504 · Cited by 9
Phosphodiesterase 4 Inhibitors in the Treatment of COPD
Tenor, H., Bundschuh, D. S., Schudt, C., Bredenbröker, D., & Hatzelmann, A. (2007) · doi:10.1002/9780470755976.ch59 · Cited by 2
Self-citation
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Glucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
New anti-inflammatory targets for chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4025 · Cited by 392
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Metadata
- Authors
- Hatzelmann, A., Morcillo, E. J., Lungarella, G., Adnot, S., Sanjar, S., Beume, R., Schudt, C., & Tenor, H.
- Venue
- Pulmonary Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 23
- Issue
- 4
- Pages
- 235-256
- ISSN
- 1094-5539 (ISSN-L)
- OpenAlex
- W1971574036
- Cited by
- 320
- References
- 221
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.